Follow this preprint
Safety and Immunogenicity of the NVX-CoV2373 Vaccine as a Booster in Adults Previously Vaccinated with the BBIBP-CorV Vaccine: An Interim Analysis
View ORCID ProfileSeth Toback, Anthony M. Marchese, Brandy Warren, Sondos Ayman, Senka Zarkovic, Islam ElTantawy, Raburn M. Mallory, Matthew Rousculp, Fahed Almarzooqi, Bartlomiej Piechowski-Jozwiak, Maria-Fernanda Bonilla, Agyad Ebrahim Bakkour, Salah Eldin Hussein, Nawal Al Kaabi
doi: https://doi.org/10.1101/2023.03.24.23287658
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Seth Toback
1Novavax Inc., Gaithersburg, Maryland, United States
MDAnthony M. Marchese
1Novavax Inc., Gaithersburg, Maryland, United States
PhDBrandy Warren
1Novavax Inc., Gaithersburg, Maryland, United States
MPHSondos Ayman
2Insights Research Organization & Solutions (IROS), Abu Dhabi, United Arab Emirates
Pharm DSenka Zarkovic
2Insights Research Organization & Solutions (IROS), Abu Dhabi, United Arab Emirates
DVMIslam ElTantawy
2Insights Research Organization & Solutions (IROS), Abu Dhabi, United Arab Emirates
Pharm DRaburn M. Mallory
1Novavax Inc., Gaithersburg, Maryland, United States
MDMatthew Rousculp
1Novavax Inc., Gaithersburg, Maryland, United States
PhDFahed Almarzooqi
3G42 Healthcare Abu Dhabi, United Arab Emirates
MDBartlomiej Piechowski-Jozwiak
4Cleveland Clinic Abu Dhabi, United Arab Emirates
MDMaria-Fernanda Bonilla
4Cleveland Clinic Abu Dhabi, United Arab Emirates
MDAgyad Ebrahim Bakkour
5Sheikh Khalifa Medical City, SEHA, Abu Dhabi, United Arab Emirates
MBBSSalah Eldin Hussein
5Sheikh Khalifa Medical City, SEHA, Abu Dhabi, United Arab Emirates
MBBSNawal Al Kaabi
5Sheikh Khalifa Medical City, SEHA, Abu Dhabi, United Arab Emirates
6College of Medicine and Health Sciences, Khalifa University, Abu Dhabi, United Arab Emirates
MBBS
Posted March 29, 2023.
Safety and Immunogenicity of the NVX-CoV2373 Vaccine as a Booster in Adults Previously Vaccinated with the BBIBP-CorV Vaccine: An Interim Analysis
Seth Toback, Anthony M. Marchese, Brandy Warren, Sondos Ayman, Senka Zarkovic, Islam ElTantawy, Raburn M. Mallory, Matthew Rousculp, Fahed Almarzooqi, Bartlomiej Piechowski-Jozwiak, Maria-Fernanda Bonilla, Agyad Ebrahim Bakkour, Salah Eldin Hussein, Nawal Al Kaabi
medRxiv 2023.03.24.23287658; doi: https://doi.org/10.1101/2023.03.24.23287658
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
1
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (420)
- Allergy and Immunology (744)
- Anesthesia (217)
- Cardiovascular Medicine (3204)
- Dermatology (270)
- Emergency Medicine (475)
- Epidemiology (13203)
- Forensic Medicine (19)
- Gastroenterology (884)
- Genetic and Genomic Medicine (5030)
- Geriatric Medicine (469)
- Health Economics (770)
- Health Informatics (3166)
- Health Policy (1121)
- Hematology (419)
- HIV/AIDS (997)
- Medical Education (467)
- Medical Ethics (124)
- Nephrology (512)
- Neurology (4777)
- Nursing (253)
- Nutrition (707)
- Oncology (2460)
- Ophthalmology (698)
- Orthopedics (275)
- Otolaryngology (335)
- Pain Medicine (318)
- Palliative Medicine (89)
- Pathology (527)
- Pediatrics (1272)
- Primary Care Research (545)
- Public and Global Health (7338)
- Radiology and Imaging (1659)
- Respiratory Medicine (960)
- Rheumatology (470)
- Sports Medicine (413)
- Surgery (532)
- Toxicology (68)
- Transplantation (227)
- Urology (197)